Notably, the OR was significantly higher in HPV-positive oropharyngeal cancer patients (n = 37) in whom the GHSR promoter was methylated (OR, 19.00; 95% CI, 1.87–193.01; P = 0.013) (Fig. 5b). Here, GHSR is linked to oropharynx cancer.